美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 088008 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No No 1983/03/03 1983/03/03 WOCKHARDT BIO AG Prescription
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 088017 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No No 1983/07/05 1983/07/05 ACTAVIS MID ATLANTIC Prescription
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 040285 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No No 1999/07/19 1999/07/19 IVAX SUB TEVA PHARMS Discontinued
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 040613 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No No 2008/02/08 2008/02/08 PAI HOLDINGS PHARM Discontinued
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 203535 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No No 2017/02/13 2017/02/13 NOVEL LABS INC Prescription
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 205731 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No No 2017/02/15 2017/02/15 PADAGIS US Prescription
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 207487 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No Yes 2017/02/21 2017/02/21 ABHAI LLC Prescription
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 204765 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No No 2017/03/06 2017/03/06 APOZEAL PHARMS Discontinued
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE 210663 001 ANDA HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE SYRUP;ORAL 1.5MG/5ML;5MG/5ML No No 2019/06/11 2019/06/11 NOSTRUM LABS INC Discontinued
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database